Earnings History Data for Virpax Pharmaceuticals, Inc. (VRPX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. It is focused on pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax Pharmaceuticals Inc. is based in WEST CHESTER, PA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | ?? | VRPX | Virpax Pharmaceuticals, Inc. | 4.46 | N/A | 0.00 | -2.60 | Virpax Pharmaceuticals GAAP EPS of -$12.97 misses by $4.77 [3/26/2024 3:27 PM] |
3.66 | -0.22 (-5.67%) |
0.0 | 0.0 (0.00%) |
2.40 - 11.77 | 4,688 | 30,000 | 0 | ||
| 12-05-2023 | AH | VRPX | Virpax Pharmaceuticals, Inc. | 10.04 | -0.13 | 0.00 | -0.44 | Virpax Pharmaceuticals GAAP EPS of -$0.13 beats by $0.17 [5/12/2023 4:18 PM] |
0.8632 | -0.02 (-1.91%) |
0.0 | 0.0 (0.00%) |
0.61 - 1.83 | 22,669 | 20,000 | 0 | ||
|
|
||||||||||||||||||
| 15-08-2022 | PM | VRPX | Virpax Pharmaceuticals, Inc. | 18.39 | -0.50 | 0.00 | -0.47 | Virpax Pharmaceuticals GAAP EPS of -$0.50 misses by $0.06 [8/15/2022 9:24 AM] |
1.63 | -0.05 (-2.98%) |
0.0 | 0.0 (0.00%) |
1.19 - 36.00 | 80,117 | 60,000 | 0 | ||
| 16-05-2022 | PM | VRPX | Virpax Pharmaceuticals, Inc. | 15.70 | -0.44 | 0.00 | -0.60 | Virpax Pharmaceuticals GAAP EPS of -$0.44 [5/16/2022 9:09 AM] |
1.36 | 0.07 (5.43%) |
1.38 | 0.09 (7.25%) |
1.25 - 36.00 | 120,906 | 550,000 | 319 | ||
| 31-03-2022 | PM | VRPX | Virpax Pharmaceuticals, Inc. | 26.12 | N/A | 0.00 | 0.00 | Virpax Pharmaceuticals GAAP EPS of -$1.81 [3/31/2022 9:47 AM] |
2.23 | -0.06 (-2.62%) |
2.33 | 0.04 (1.75%) |
1.75 - 36.00 | 85,904 | 120,000 | 1,157 | ||
| 15-11-2021 | PM | VRPX | Virpax Pharmaceuticals, Inc. | 49.09 | -0.53 | 0.00 | 0.00 | Virpax Pharmaceuticals reports Q3 results [11/15/2021 8:55 AM] |
4.22 | -0.09 (-2.09%) |
4.15 | -0.16 (-3.71%) |
3.70 - 36.00 | 237,414 | 360,000 | 14,485 | ||